A large-scale study of bone marrow involvement in patients with Hodgkin's lymphoma.
暂无分享,去创建一个
A. Levis | M. Boccadoro | M. Aglietta | G. Saglio | T. Guglielmelli | A. Gallamini | U. Vitolo | A. Tonso | F. Salvi | P. Gavarotti | L. Orsucci | D. Pietrasanta | L. Godio | E. Gallo | G. Ciravegna | F. Di Vito | E. Raviolo | D. Rota Scalabrini | E. Scassa
[1] A. Alavi,et al. Utility of FDG-PET scanning in lymphoma by WHO classification. , 2003, Blood.
[2] J. Matthews,et al. Optimum trephine length in the assessment of bone marrow involvement in patients with diffuse large cell lymphoma. , 2003, Annals of oncology : official journal of the European Society for Medical Oncology.
[3] J. Radford,et al. The value of bone marrow examination in the staging of Hodgkin's lymphoma: a review of 955 cases seen in a regional cancer centre , 2002, British journal of haematology.
[4] M. Slovak,et al. Diagnostic utility of bilateral bone marrow examination , 2002, Cancer.
[5] B. Bain. Bone marrow trephine biopsy. , 2001, Journal of clinical pathology.
[6] J Kotzerke,et al. 2‐(fluorine‐18)fluoro‐2‐deoxy‐D‐glucose positron emission tomography in the detection and staging of malignant lymphoma , 2001, Cancer.
[7] G. Jerusalem,et al. Whole-body positron emission tomography using 18F-fluorodeoxyglucose compared to standard procedures for staging patients with Hodgkin's disease. , 2001, Haematologica.
[8] S. Hain,et al. 2-Fluorine-18-fluoro-2-deoxy-D glucose positron emission tomography in the pretreatment staging of Hodgkin's disease: influence on patient management in a single institution. , 2000, Annals of oncology : official journal of the European Society for Medical Oncology.
[9] L. Avioli,et al. Hodgkin's disease , 1969, Bone Marrow Transplantation.
[10] G. Demir,et al. Magnetic resonance imaging of bone marrow versus bone marrow biopsy in malignant lymphoma , 1999, Pathology & Oncology Research.
[11] J. Armitage,et al. A prognostic score for advanced Hodgkin's disease. International Prognostic Factors Project on Advanced Hodgkin's Disease. , 1998, The New England journal of medicine.
[12] J Kotzerke,et al. Whole-body 2-[18F]-fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) for accurate staging of Hodgkin's disease. , 1998, Annals of oncology : official journal of the European Society for Medical Oncology.
[13] Â. Maiolino,et al. Clinical factors predictive of bone marrow involvement in Hodgkin's disease. , 1997, Leukemia & lymphoma.
[14] S. Fava,et al. Bone marrow biopsy for staging Hodgkin's lymphoma: the value of bilateral or unilateral trephine biopsy. , 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[15] S. Hancock,et al. Brief chemotherapy, Stanford V, and adjuvant radiotherapy for bulky or advanced-stage Hodgkin's disease: a preliminary report. , 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[16] V. Diehl,et al. Bone marrow involvement in Hodgkin's disease: an analysis of 135 consecutive cases. German Hodgkin's Lymphoma Study Group. , 1995, Journal of Clinical Oncology.
[17] P. Gobbi,et al. Estimate of expected survival at diagnosis in Hodgkin's disease: a means of weighting prognostic factors and a tool for treatment choice and clinical research. A report from the International Database on Hodgkin's Disease (IDHD). , 1994, Haematologica.
[18] P. Gobbi,et al. MOPP/EBV/CAD hybrid chemotherapy with or without limited radiotherapy in advanced or unfavorably presenting Hodgkin's disease: a report from the Italian Lymphoma Study Group. , 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[19] K. McNally,et al. Audit of bone marrow trephines. , 1992, Journal of clinical pathology.
[20] P. Donnan,et al. A numerical prognostic index for clinical use in identification of poor-risk patients with Hodgkin's disease at diagnosis. The Scotland and Newcastle Lymphoma Group (SNLG) Therapy Working Party. , 1992, Leukemia & lymphoma.
[21] A. Shields,et al. Detection of lymphomatous bone marrow involvement with magnetic resonance imaging. , 1991, Blood.
[22] A. Santoro,et al. Alternating versus hybrid MOPP-ABVD in Hodgkin's disease: the Milan experience. , 1991, Annals of oncology : official journal of the European Society for Medical Oncology.
[23] M Tubiana,et al. Report of a committee convened to discuss the evaluation and staging of patients with Hodgkin's disease: Cotswolds meeting. , 1989, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[24] N. Nissen,et al. Prognostic factors in Hodgkin's disease stage IV , 1988, European journal of haematology.
[25] E. Macintyre,et al. The value of staging bone marrow trephine biopsy in Hodgkin's Disease , 1987, European journal of haematology.
[26] A. Shields,et al. The detection of bone marrow involvement by lymphoma using magnetic resonance imaging. , 1987, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[27] A. Santoro,et al. Alternating non-cross-resistant combination chemotherapy or MOPP in stage IV Hodgkin's disease. A report of 8-year results. , 1986, Annals of internal medicine.
[28] G. Papa,et al. Bone Marrow Involvement at Onset of Hodgkin's Disease , 1983, Tumori.
[29] D. Huhn,et al. Assessment of bone marrow histology in Hodgkin's disease: correlation with clinical factors , 1982, British journal of haematology.
[30] D. O'Carroll,et al. Bone marrow manifestations of Hodgkin's disease , 1976, Cancer.
[31] G. Bonadonna,et al. Combination chemotherapy of Hodgkin's disease with adriamycin, bleomycin, vinblastine, and imidazole carboxamide versus MOPP , 1975, Cancer.
[32] C. Bloomfield,et al. Bilateral trephine bone marrow biopsies in lymphoma and other neoplastic diseases. , 1975, Annals of internal medicine.
[33] S. Rosenberg. Hodgkin's disease of the bone marrow. , 1971, Cancer research.
[34] M Tubiana,et al. Report of the Committee on Hodgkin's Disease Staging Classification. , 1971, Cancer research.
[35] R. Silver,et al. Importance of bone marrow biopsy in the clinical staging of hodgkin's disease , 1970, Cancer.
[36] Treatment of Hodgkin's disease. , 1967, The Medical annals of the District of Columbia.